Novel Cancer Therapies: The Emerging Role of Immunotherapy

PROGRAM DESCRIPTION This educational activity will explore the growing role of immunotherapy in treating patients with both hematologic and solid tumor malignancies. Approvals for novel indications as well as place ...

PROGRAM DESCRIPTION
This educational activity will explore the growing role of immunotherapy in treating patients with both hematologic and solid tumor malignancies. Approvals for novel indications as well as place in therapy and association with biomarkers predictive of response will be discussed. Patient cases will be utilized to highlight therapy selection as well as common adverse effects. Specific focus will also include toxicity management strategies.

EDUCATIONAL OBJECTIVES
At the conclusion of this application-based educational activity, participants should be able to:Evaluate the current and future places in therapy for immunotherapy agents, including novel indications in both hematologic and solid tumor malignancies.Identify common toxicities associated with immunotherapy and recommend best practices for their management.Apply strategies for the appropriate selection of immunotherapy in patient scenarios, including consideration of biomarkers and unique patient characteristics.

---

Write the first review

Resource tags